Skip to content

SION SION Debt-to-equity

Debt-to-equity at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
0.1×0.0×
AbbVie logo
AbbVieABBV
46.6×+38.6×
Septerna, Inc. logo
Septerna, Inc.SEPN
0.1×
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
0.0×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.1×-0.1×

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.8B
Enterprise value$1.74B

Returns & leverage

See full
Return on equity-26.7%
Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

Based on the most recent quarter.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's debt-to-equity?
SION (SION) reported debt-to-equity of 0× in Q1 2026.
How has SION's debt-to-equity changed year-over-year?
SION's debt-to-equity increased by 7.8% year-over-year, from 0× to 0×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.